Novo Nordisk | NVO - PE Price to Earnings

Stock Price
41.17
Daily Change
-0.01 -0.02%
Monthly
16.70%
Yearly
-36.80%
Q2 Forecast
39.20

Novo Nordisk reported 13.92 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
ANI Pharmaceuticals 37.99 60.68 Dec/2025
Aurora Cannabis 23.27 0 Sep/2025
Bausch Health Companies 6.98 0.41 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Corcept Therapeutics 41.9 52.28 Dec/2025
Drreddys Laboratories 18.27 0.84 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
Merck 13.92 5.08 Dec/2025
Novartis 20.17 2.32 Mar/2026
Novo Nordisk 12.78 0.01 Dec/2025
Novo Nordisk 13.92 4.91 Sep/2025
Pacira 52.68 23.44 Dec/2025
Perrigo 58.96 24.65 Dec/2025
Phibro Animal Health 13.82 4.04 Dec/2025
Prestige Brands 15.31 3.1 Dec/2025
Sanofi 11.84 0.14 Mar/2026
Supernus Pharmaceuticals 110.38 71.27 Dec/2025
Zoetis 20.42 2.84 Dec/2025